AFT shares drop 6.3% after ticking off over Maxiclear marketing

AFT shares drop 6.3% after ticking off over Maxiclear marketing
Paul McBeth
By Paul McBeth Aug. 16 (BusinessDesk) - AFT Pharmaceutical shares dropped 6.3 percent on very thin volumes after the maker of Maxigesic was one of two companies warned by the Commerce Commission over the marketing and packaging of painkillers.  The shares fell 18 cents to $2.66 with just 5,000 shares changing hands after the regulator said it warned AFT and GlaxoSmithKline Consumer Healthcare New Zealand that the packaging and marketing of various painkillers probably breached the Fair Trading Act by claiming to treat specific ailments. T...